Published in J Clin Microbiol on December 01, 2003
Phenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma. J Clin Microbiol (2009) 1.71
In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother (2004) 1.39
Molecular identification of black-grain mycetoma agents. J Clin Microbiol (2006) 1.28
New species of Madurella, causative agents of black-grain mycetoma. J Clin Microbiol (2012) 1.18
Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma. J Clin Microbiol (2015) 0.92
Rapid identification of black grain eumycetoma causative agents using rolling circle amplification. PLoS Negl Trop Dis (2014) 0.85
Novel Taxa Associated with Human Fungal Black-Grain Mycetomas: Emarellia grisea gen. nov., sp. nov., and Emarellia paragrisea sp. nov. J Clin Microbiol (2016) 0.85
Mycetoma of the foot--diagnosis of the etiologic agent and surgical treatment. Am J Trop Med Hyg (2015) 0.81
Mapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling. PLoS Negl Trop Dis (2014) 0.81
Subcutaneous Mycotic Cyst Caused by Roussoella percutanea in a UK Renal Transplant Patient. Mycopathologia (2017) 0.77
A 48-year-old male immigrant with a painful foot mass. Can J Infect Dis Med Microbiol (2014) 0.75
The "dot-in-circle" sign in musculoskeletal mycetoma on magnetic resonance imaging and ultrasonography. Springerplus (2014) 0.75
Coexistent actinomycosis and eumycetoma in an immunocompetent patient. Indian J Dermatol (2014) 0.75
Rapid and robust identification of the agents of black-grain mycetoma by MALDI-ToF mass spectrometry. J Clin Microbiol (2017) 0.75
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
Diagnostic problems with imported cases of mycetoma in The Netherlands. Mycoses (1993) 2.12
Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol (1999) 1.92
Mycetoma. Dermatol Clin (1996) 1.86
Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol (2003) 1.59
A contribution to the study of the causal organisms of maduromycosis. Trans R Soc Trop Med Hyg (1954) 1.42
Mycetoma of the foot caused by Cylindrocarpon destructans. J Clin Microbiol (1991) 1.26
Nocardia, nocardiosis and mycetoma. Med Mycol (1998) 1.15
Mycetomas in Mali: causative agents and geographic distribution. Am J Trop Med Hyg (1996) 0.95
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med (2010) 8.50
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med (2012) 4.76
Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest (2004) 2.86
Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev (2002) 2.43
Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis (2004) 2.36
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J Clin Invest (2004) 2.25
Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule". Clin Infect Dis (2004) 2.15
Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med (2013) 1.95
Methicillin-resistant Staphylococcus aureus in meat products, the Netherlands. Emerg Infect Dis (2007) 1.94
Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J Infect Dis (2010) 1.92
Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J Clin Microbiol (2005) 1.88
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J Clin Microbiol (2010) 1.73
Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis (2007) 1.70
Propionibacterium acnes: an agent of prosthetic joint infection and colonization. J Infect (2007) 1.70
Host- and tissue-specific pathogenic traits of Staphylococcus aureus. J Bacteriol (2005) 1.70
Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med (2008) 1.64
Human factor in Staphylococcus aureus nasal carriage. Infect Immun (2004) 1.64
Molecular evidence for dissemination of unique Campylobacter jejuni clones in Curaçao, Netherlands Antilles. J Clin Microbiol (2003) 1.64
Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis (2009) 1.62
Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun (2007) 1.60
Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Microbiol (2002) 1.59
Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 1.54
Loss of the mecA gene during storage of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol (2005) 1.49
RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses. J Clin Microbiol (2008) 1.49
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis. J Antimicrob Chemother (2010) 1.47
Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis (2006) 1.45
Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis (2002) 1.44
Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int (2005) 1.42
Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother (2005) 1.42
The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis. Genome Res (2007) 1.40
Patterns of resistance associated with integrons, the extended-spectrum beta-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J Clin Microbiol (2003) 1.40
In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother (2004) 1.39
Prevalence of ST9 methicillin-resistant Staphylococcus aureus among pigs and pig handlers in Malaysia. J Clin Microbiol (2009) 1.34
Associations between Staphylococcus aureus Genotype, Infection, and In-Hospital Mortality: A Nested Case-Control Study. J Infect Dis (2005) 1.29
Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method. J Clin Microbiol (2008) 1.28
The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect Immun (2008) 1.25
Overlapping population structures of nasal isolates of Staphylococcus aureus from healthy Dutch and American individuals. J Clin Microbiol (2007) 1.23
Nasopharyngeal carriage of potential bacterial pathogens related to day care attendance, with special reference to the molecular epidemiology of Haemophilus influenzae. J Clin Microbiol (2002) 1.23
Dynamics and determinants of Staphylococcus aureus carriage in infancy: the Generation R Study. J Clin Microbiol (2008) 1.22
Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis (2010) 1.20
Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity. BMC Genomics (2007) 1.20
Dislocation after total hip arthroplasty using Hueter anterior approach. J Arthroplasty (2008) 1.19
Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother (2005) 1.18
Rapid differentiation between livestock-associated and livestock-independent Staphylococcus aureus CC398 clades. PLoS One (2013) 1.16
Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae. Microbiology (2010) 1.15
Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol (2003) 1.15
Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps? FEMS Microbiol Rev (2007) 1.14
TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol (2010) 1.14
Comparison of multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), and amplified fragment length polymorphism (AFLP) for genetic typing of Staphylococcus aureus. J Microbiol Methods (2007) 1.14
Multilocus sequence typing of Staphylococcus aureus with DNA array technology. J Clin Microbiol (2003) 1.13
Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect Immun (2010) 1.13
Correlation between genotypic diversity, lipooligosaccharide gene locus class variation, and caco-2 cell invasion potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotyping. Appl Environ Microbiol (2009) 1.13
Recent emergence of Staphylococcus aureus clonal complex 398 in human blood cultures. PLoS One (2012) 1.12
Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. J Clin Microbiol (2005) 1.12
A continuous quality-improvement program reduces nosocomial infection rates in the ICU. Intensive Care Med (2003) 1.12
The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes Infect (2007) 1.11
Diagnosis of active tuberculosis by e-nose analysis of exhaled air. Tuberculosis (Edinb) (2012) 1.11
Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange. Infect Immun (2004) 1.11
Major epidemic clones of Staphylococcus aureus in Nigeria. Microb Drug Resist (2005) 1.11
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun (2011) 1.10
Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect (2007) 1.09
Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol (2009) 1.09
Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One (2013) 1.08
Rapid typing of extended-spectrum β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates by use of SpectraCell RA. J Clin Microbiol (2012) 1.07
Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol (2003) 1.07
Comparison of carboxylated and Penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins. J Immunol Methods (2008) 1.06
A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol (2003) 1.06
Isolation of nontuberculous mycobacteria in Zambia: eight case reports. J Clin Microbiol (2005) 1.06
Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect (2009) 1.05
Listeria monocytogenes-associated joint and bone infections: a study of 43 consecutive cases. Clin Infect Dis (2011) 1.05
Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J Clin Microbiol (2006) 1.04
Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun (2011) 1.03
Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002. Trop Med Int Health (2012) 1.03
A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus. J Med Microbiol (2010) 1.02
Identification of a sialate O-acetyltransferase from Campylobacter jejuni: demonstration of direct transfer to the C-9 position of terminalalpha-2, 8-linked sialic acid. J Biol Chem (2006) 1.01
Immunotherapeutic approaches against Staphylococcus aureus. Immunotherapy (2011) 1.01
Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J Clin Microbiol (2006) 1.01
Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis. Tuberculosis (Edinb) (2012) 1.00
A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis. J Microbiol Methods (2004) 1.00
Disease induction by human microbial pathogens in plant-model systems: potential, problems and prospects. Drug Discov Today (2006) 1.00
Characterization of β-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J Proteome Res (2011) 1.00
First report of subcutaneous phaeohyphomycosis caused by Ochroconis tshawytschae in an immunocompetent patient. Med Mycol (2012) 1.00
The role of nasal carriage in Staphylococcus aureus burn wound colonization. FEMS Immunol Med Microbiol (2009) 1.00
Unusually high prevalence of panton-valentine leukocidin genes among methicillin-sensitive Staphylococcus aureus strains carried in the Indonesian population. J Clin Microbiol (2008) 0.99